These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 14970936)
1. Adoptive immunotherapy with antigen-specific T cells in myeloma: a model of tumor-specific donor lymphocyte infusion. Kwak LW; Neelapu SS; Bishop MR Semin Oncol; 2004 Feb; 31(1):37-46. PubMed ID: 14970936 [TBL] [Abstract][Full Text] [Related]
2. Successful generation of sperm protein 17 (Sp17)-specific cytotoxic T lymphocytes from normal donors: implication for tumour-specific adoptive immunotherapy following allogeneic stem cell transplantation for Sp17-positive multiple myeloma. Chiriva-Internati M; Wang Z; Salati E; Wroblewski D; Lim SH Scand J Immunol; 2002 Oct; 56(4):429-33. PubMed ID: 12234264 [TBL] [Abstract][Full Text] [Related]
4. Donor lymphocyte infusion: the use of alloreactive and tumor-reactive lymphocytes for immunotherapy of malignant and nonmalignant diseases in conjunction with allogeneic stem cell transplantation. Slavin S; Morecki S; Weiss L; Or R J Hematother Stem Cell Res; 2002 Apr; 11(2):265-76. PubMed ID: 11983098 [TBL] [Abstract][Full Text] [Related]
5. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
6. A reduction of recipient regulatory T cells by cyclophosphamide contributes to an anti-tumor effect of nonmyeloablative allogeneic stem cell transplantation in mice. Takeuchi A; Eto M; Yamada H; Tatsugami K; Naito S; Yoshikai Y Int J Cancer; 2012 Jan; 130(2):365-76. PubMed ID: 21351096 [TBL] [Abstract][Full Text] [Related]
7. Partial T cell-depleted allogeneic stem cell transplantation following reduced-intensity conditioning creates a platform for immunotherapy with donor lymphocyte infusion and recipient dendritic cell vaccination in multiple myeloma. Levenga H; Schaap N; Maas F; Esendam B; Fredrix H; Greupink-Draaisma A; de Witte T; Dolstra H; Raymakers R Biol Blood Marrow Transplant; 2010 Mar; 16(3):320-32. PubMed ID: 19835972 [TBL] [Abstract][Full Text] [Related]